140 related articles for article (PubMed ID: 23197543)
21. Evaluation of the impact of transient interruption of antiangiogenic treatment using ultrasound-based techniques in a murine model of hepatocellular carcinoma.
Marinelli S; Salvatore V; Baron Toaldo M; Milazzo M; Croci L; Venerandi L; Pecorelli A; Palamà C; Diana A; Bolondi L; Piscaglia F
BMC Cancer; 2014 Jun; 14():403. PubMed ID: 24902850
[TBL] [Abstract][Full Text] [Related]
22. The high angiogenic activity in very early breast cancer enables reliable imaging with VEGFR2-targeted microbubbles (BR55).
Bzyl J; Palmowski M; Rix A; Arns S; Hyvelin JM; Pochon S; Ehling J; Schrading S; Kiessling F; Lederle W
Eur Radiol; 2013 Feb; 23(2):468-75. PubMed ID: 22878592
[TBL] [Abstract][Full Text] [Related]
23. Ultrasound-Targeted Microbubble Destruction Enhances the Antitumor Efficacy of Doxorubicin in a Mouse Hepatocellular Carcinoma Model.
Wu Y; Sun T; Tang J; Liu Y; Li F
Ultrasound Med Biol; 2020 Mar; 46(3):679-689. PubMed ID: 31882167
[TBL] [Abstract][Full Text] [Related]
24. Acoustic Characterization and Enhanced Ultrasound Imaging of Long-Circulating Lipid-Coated Microbubbles.
Li H; Yang Y; Zhang M; Yin L; Tu J; Guo X; Zhang D
J Ultrasound Med; 2018 May; 37(5):1243-1256. PubMed ID: 29127707
[TBL] [Abstract][Full Text] [Related]
25. Vascular endothelial growth factor receptor type 2-targeted contrast-enhanced US of pancreatic cancer neovasculature in a genetically engineered mouse model: potential for earlier detection.
Pysz MA; Machtaler SB; Seeley ES; Lee JJ; Brentnall TA; Rosenberg J; Tranquart F; Willmann JK
Radiology; 2015 Mar; 274(3):790-9. PubMed ID: 25322341
[TBL] [Abstract][Full Text] [Related]
26. Targeted microbubbles for imaging tumor angiogenesis: assessment of whole-body biodistribution with dynamic micro-PET in mice.
Willmann JK; Cheng Z; Davis C; Lutz AM; Schipper ML; Nielsen CH; Gambhir SS
Radiology; 2008 Oct; 249(1):212-9. PubMed ID: 18695212
[TBL] [Abstract][Full Text] [Related]
27. Blood flow changes in hepatocellular carcinoma after the administration of thalidomide assessed by reperfusion kinetics during microbubble infusion: preliminary results.
Bertolotto M; Pozzato G; Crocè LS; Nascimben F; Gasparini C; Cova MA; Tiribelli C
Invest Radiol; 2006 Jan; 41(1):15-21. PubMed ID: 16355035
[TBL] [Abstract][Full Text] [Related]
28. BR55 Ultrasound Molecular Imaging of Clear Cell Renal Cell Carcinoma Reflects Tumor Vascular Expression of VEGFR-2 in a Patient-Derived Xenograft Model.
Courcier J; Leguerney I; Benatsou B; Pochon S; Tardy I; Albiges L; Cournède PH; De La Taille A; Lassau N; Ingels A
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003400
[TBL] [Abstract][Full Text] [Related]
29. VEGFR2-targeted molecular imaging in the mouse embryo: an alternative to the tumor model.
Denbeigh JM; Nixon BA; Hudson JM; Puri MC; Foster FS
Ultrasound Med Biol; 2014 Feb; 40(2):389-99. PubMed ID: 24342913
[TBL] [Abstract][Full Text] [Related]
30. Value of wash-in and wash-out time in the diagnosis between hepatocellular carcinoma and other hepatic nodules with similar vascular pattern on contrast-enhanced ultrasound.
Kong WT; Wang WP; Huang BJ; Ding H; Mao F
J Gastroenterol Hepatol; 2014 Mar; 29(3):576-80. PubMed ID: 24118042
[TBL] [Abstract][Full Text] [Related]
31. Effects of acoustic radiation force on the binding efficiency of BR55, a VEGFR2-specific ultrasound contrast agent.
Frinking PJ; Tardy I; Théraulaz M; Arditi M; Powers J; Pochon S; Tranquart F
Ultrasound Med Biol; 2012 Aug; 38(8):1460-9. PubMed ID: 22579540
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness of localized ultrasound-targeted microbubble destruction with doxorubicin liposomes in H22 mouse hepatocellular carcinoma model.
Zhu F; Jiang Y; Luo F; Li P
J Drug Target; 2015 May; 23(4):323-34. PubMed ID: 25609362
[TBL] [Abstract][Full Text] [Related]
33. Ultrasound-triggered therapeutic microbubbles enhance the efficacy of cytotoxic drugs by increasing circulation and tumor drug accumulation and limiting bioavailability and toxicity in normal tissues.
Ingram N; McVeigh LE; Abou-Saleh RH; Maynard J; Peyman SA; McLaughlan JR; Fairclough M; Marston G; Valleley EMA; Jimenez-Macias JL; Charalambous A; Townley W; Haddrick M; Wierzbicki A; Wright A; Volpato M; Simpson PB; Treanor DE; Thomson NH; Loadman PM; Bushby RJ; Johnson BRG; Jones PF; Evans JA; Freear S; Markham AF; Evans SD; Coletta PL
Theranostics; 2020; 10(24):10973-10992. PubMed ID: 33042265
[TBL] [Abstract][Full Text] [Related]
34. Microbubble-enhanced ultrasound for the antivascular treatment and monitoring of hepatocellular carcinoma.
D'Souza JC; Sultan LR; Hunt SJ; Gade TP; Karmacharya MB; Schultz SM; Brice AK; Wood AKW; Sehgal CM
Nanotheranostics; 2019; 3(4):331-341. PubMed ID: 31687321
[No Abstract] [Full Text] [Related]
35. Sonographic comparison of intraarterial CO2 and helium microbubbles for detection of hepatocellular carcinoma: preliminary observations.
Nishiharu T; Yamashita Y; Arakawa A; Sumi S; Mitsuzaki K; Matsukawa T; Takahashi M
Radiology; 1998 Mar; 206(3):767-71. PubMed ID: 9494499
[TBL] [Abstract][Full Text] [Related]
36. Semiquantitative characterization of hepatocellular carcinoma (HCC)--perfusion with contrast-enhanced ultrasound and perfusion analysis.
Schacherer D; Girlich C; Wiest R; Büttner R; Schölmerich J; Feuerbach S; Zorger N; Hamer OW; Jung EM
Clin Hemorheol Microcirc; 2010; 44(2):97-105. PubMed ID: 20203364
[TBL] [Abstract][Full Text] [Related]
37. Dynamic contrast-enhanced ultrasound (DCE-US) for the characterization of hepatocellular carcinoma and cholangiocellular carcinoma.
Wildner D; Pfeifer L; Goertz RS; Bernatik T; Sturm J; Neurath MF; Strobel D
Ultraschall Med; 2014 Dec; 35(6):522-7. PubMed ID: 25202903
[TBL] [Abstract][Full Text] [Related]
38. Contrast-Enhanced Ultrasound with VEGFR2-Targeted Microbubbles for Monitoring Regorafenib Therapy Effects in Experimental Colorectal Adenocarcinomas in Rats with DCE-MRI and Immunohistochemical Validation.
Eschbach RS; Clevert DA; Hirner-Eppeneder H; Ingrisch M; Moser M; Schuster J; Tadros D; Schneider M; Kazmierczak PM; Reiser M; Cyran CC
PLoS One; 2017; 12(1):e0169323. PubMed ID: 28060884
[TBL] [Abstract][Full Text] [Related]
39. Intensity-Based Assessment of Microbubble-Enhanced Ultrasonography: Phase-Related Diagnostic Ability for Cellular Differentiation of Hepatocellular Carcinoma.
Kondo T; Maruyama H; Kiyono S; Sekimoto T; Shimada T; Takahashi M; Ogasawara S; Suzuki E; Ooka Y; Tawada A; Chiba T; Kanai F; Yokosuka O
Ultrasound Med Biol; 2015 Dec; 41(12):3079-87. PubMed ID: 26371403
[TBL] [Abstract][Full Text] [Related]
40. Ultrasound Molecular Imaging of the Breast Cancer Neovasculature using Engineered Fibronectin Scaffold Ligands: A Novel Class of Targeted Contrast Ultrasound Agent.
Abou-Elkacem L; Wilson KE; Johnson SM; Chowdhury SM; Bachawal S; Hackel BJ; Tian L; Willmann JK
Theranostics; 2016; 6(11):1740-52. PubMed ID: 27570547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
